Correlation Between HTG Molecular and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both HTG Molecular and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HTG Molecular Diagnostics and bioAffinity Technologies,, you can compare the effects of market volatilities on HTG Molecular and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and BioAffinity Technologies,.
Diversification Opportunities for HTG Molecular and BioAffinity Technologies,
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between HTG and BioAffinity is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of HTG Molecular i.e., HTG Molecular and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between HTG Molecular and BioAffinity Technologies,
Given the investment horizon of 90 days HTG Molecular Diagnostics is expected to generate 2.35 times more return on investment than BioAffinity Technologies,. However, HTG Molecular is 2.35 times more volatile than bioAffinity Technologies,. It trades about 0.01 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about 0.02 per unit of risk. If you would invest 298.00 in HTG Molecular Diagnostics on August 29, 2024 and sell it today you would lose (241.00) from holding HTG Molecular Diagnostics or give up 80.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 31.45% |
Values | Daily Returns |
HTG Molecular Diagnostics vs. bioAffinity Technologies,
Performance |
Timeline |
HTG Molecular Diagnostics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
bioAffinity Technologies, |
HTG Molecular and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HTG Molecular and BioAffinity Technologies,
The main advantage of trading using opposite HTG Molecular and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.HTG Molecular vs. bioAffinity Technologies, | HTG Molecular vs. Psychemedics | HTG Molecular vs. Precipio | HTG Molecular vs. Intelligent Bio Solutions |
BioAffinity Technologies, vs. Intelligent Bio Solutions | BioAffinity Technologies, vs. T2 Biosystms | BioAffinity Technologies, vs. Genetic Technologies | BioAffinity Technologies, vs. Psychemedics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |